2,540 jobs
Program Management Sr. ManagerNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Associate Director, Marketing, International, EndocrinologyNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Associate Director, Marketing, InternationalNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Senior Manager, Accounting and Controlling, InternationalNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Field Reimbursement Manager - NortheastNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Associate Director, Patient Support ServicesNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Field Reimbursement Manager - SoutheastNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Analytical Development - Manager / Sr. ManagerNew
201-500 employees
Sequoia Post-IPO $1.1B valuation
What they do:
BridgeBio Pharma focuses on genetic disease therapies and develops those assets with the right approach in supporting R&D.
Biotech
Life Sciences
Quick facts:
📍HQ: San Francisco Bay Area, California, USA
201-500 employees
Founded: 2014
Take action:
See who works here 🤝
Check company site 📌
Vice President, MarketingNew
101-200 employees
Bessemer Post-IPO $2.0B valuation
What they do:
Kymera Therapeutics is pioneering a transformative approach to treating previously untreatable diseases.
Healthcare
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
101-200 employees
Founded: 2016
Take action:
See who works here 🤝
Check company site 📌
Talent Acquisition ConsultantNew
101-200 employees
Bessemer Post-IPO $2.0B valuation
What they do:
Kymera Therapeutics is pioneering a transformative approach to treating previously untreatable diseases.
Healthcare
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
101-200 employees
Founded: 2016
Take action:
See who works here 🤝
Check company site 📌
Vice President, Pricing & Market AccessNew
101-200 employees
Bessemer Post-IPO $2.0B valuation
What they do:
Kymera Therapeutics is pioneering a transformative approach to treating previously untreatable diseases.
Healthcare
Biotech
Quick facts:
📍HQ: Boston, Massachusetts, USA
101-200 employees
Founded: 2016
Take action:
See who works here 🤝
Check company site 📌